Back to Search Start Over

Mesenchymal and Neural Stem Cell-Derived Exosomes in Treating Alzheimer's Disease.

Authors :
Wang, Hongmin
Huber, Christa C.
Li, Xiao-Ping
Source :
Bioengineering (Basel); Feb2023, Vol. 10 Issue 2, p253, 14p
Publication Year :
2023

Abstract

As the most common form of dementia and a progressive neurodegenerative disorder, Alzheimer's disease (AD) affects over 10% world population with age 65 and older. The disease is neuropathologically associated with progressive loss of neurons and synapses in specific brain regions, deposition of amyloid plaques and neurofibrillary tangles, neuroinflammation, blood–brain barrier (BBB) breakdown, mitochondrial dysfunction, and oxidative stress. Despite the intensive effort, there is still no cure for the disorder. Stem cell-derived exosomes hold great promise in treating various diseases, including AD, as they contain a variety of anti-apoptotic, anti-inflammatory, and antioxidant components. Moreover, stem cell-derived exosomes also promote neurogenesis and angiogenesis and can repair damaged BBB. In this review, we will first outline the major neuropathological features associated with AD; subsequently, a discussion of stem cells, stem cell-secreted exosomes, and the major exosome isolation methods will follow. We will then summarize the recent data involving the use of mesenchymal stem cell- or neural stem cell-derived exosomes in treating AD. Finally, we will briefly discuss the challenges, perspectives, and clinical trials using stem cell-derived exosomes for AD therapy. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
23065354
Volume :
10
Issue :
2
Database :
Complementary Index
Journal :
Bioengineering (Basel)
Publication Type :
Academic Journal
Accession number :
162086884
Full Text :
https://doi.org/10.3390/bioengineering10020253